Sex-specific differences in levels of morphine, morphine-3-glucuronide, and morphine antinociception in rats

Pain

Volumn 95, Issue 1-2, 2002, Pages 65-74

  Baker, Lanning ^a   Ratka, Anna ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

Morphine; Morphine 3 glucuronide; Pain; Rats; Sex

Indexed keywords

MORPHINE; MORPHINE 3 GLUCURONIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG GLUCURONIDATION; FEMALE; GONADECTOMY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ANALGESICS; ANALGESICS, OPIOID; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; MALE; MORPHINE; MORPHINE DERIVATIVES; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS;

EID: 0036145364     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(01)00376-1     Document Type: Article

References (78)

1. Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients
2. Effects of morphine glucuronides on the function of opioid receptors in human SK-N-SH cells
3. Sex differences in the effects of morphine and stress on visceral pain
4. Ovarian steroids and modulation of morphine-induced analgesia and catalepsy in female rats
5. Alterations in brain opiate receptor mechanisms on proestrous afternoon
6. Desensitization of brain opiate receptor mechanisms by gonadal steroid treatment which stimulate LH secretion
7. Morphine, morphine-6-glucuronide and morphine-3-glucuronide concentrations in plasma and cerebrospinal fluid during long-term high-dose intrathecal morphine administration
8. Extrahepatic morphine metabolism in man during the anhepatic phase of orthotopic liver transplantation
9. The metabolism of morphine and heroin in man
10. Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation
11. Mu receptor binding of some commonly used opioids and their metabolites
12. Purification and properties of two rat liver phenobarbital-inducible UDP-glucuronosyl transferases that catalyze the glucuronidation of opioids
13. Sex-related differences in the antinociceptive effects of opioids: Importance of rat genotype, nociceptive stimulus intensity, and efficacy at the μ opioid receptor
14. The enantioselective glucuronidation of morphine in rats and humans: Evidence for the involvement of more than one UDP-glucuronosyltransferase isoenzyme
15. The depression of spinal inhibition by morphine
16. Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides after oral morphine. The influence of renal failure
17. Gender differences in rat neuropathic pain sensitivity is dependent on strain
18. Differential effects of ovarian hormones on reactivity to electric foot-shock in rats
19. Lack of morphine-6-glucuronide antinociception after morphine treatment. Is morphine-3-glucuronide involved?
20. Sex-related hormonal influences on pain and analgesic responses
21. Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine
22. Morphine-3-glucuronide has a minor effect on morphine antinociception. Pharmacodynamic modeling
23. Kappa-opioids produce significantly greater analgesia in women than men
24. Gender differences in analgesic response to the kappa-opioid pentazocine
25. A simple, rapid method for simultaneous determination of morphine and its principal metabolites in plasma using high-performance liquid chromatography and fluorometric detection
26. Antinociceptive and ventilatory effects of the morphine metabolites: Morphine-6-glucuronide and morphine-3-glucuronide
27. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat
28. Enhancement of morphine analgesia by the GABAB agonist baclofen
29. Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain
30. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations
31. Repetitive exposure to the hot-plate test produces stress induced analgesia and alters β-endorphin neuronal transmission within the periaqueductal gray of the rat
32. Influence of menstrual cycle on neuroendocrine and behavioral responses to an opiate agonist in humans: Preliminary results
33. Biotransformation of morphine and fentanyl in anhepatic drugs
34. Induction of two UDP-glucuronosyltransferease isoforms sensitive to phenobarbital that are involved in morphine glucuronidation: Production of isoform-selective antipeptide antibodies toward UGT1.1r and UGT2B1
35. Sex differences in the antinociceptive effects of the enkephalinase inhibitor, SCH 34826
36. Roles of gender, gonadectomy, and estrous prophase in the analgesic effects of intracerebroventricular morphine in rats
37. Sex differences in supraspinal morphine analgesia are dependent on genotype
38. Roles of gender and gonadectomy in pilocarpine and clonidine analgesia in rats
39. Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds
40. Species differences in site-specific glucuronidation of morphine
41. Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta-, and kappa- specific opioid binding sites in cerebral membranes
42. Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers
43. Identification of glucuronide metabolites of benzomorphan narcotic analgesic drugs in bile from the isolated perfused rat liver by gas chromatography and mass spectrometry
44. Genetic variability in morphine sensitivity and tolerance between different strains of rats
45. Oral morphine in cancer pain: Influences on morphine and metabolite concentration
46. The role of morphine glucuronides in cancer pain
47. The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine
48. Sex differences in the antagonism of swim stress-induced analgesia: Effects of gonadectomy and estrogen replacement
49. Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype
50. Chemical synthesis and analgesic effect of morphine ethereal sulphates
51. Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine-6-glucuronide
52. Effect of prior morphine-3-glucuronide exposure on morphine disposition and antinociception
53. Morphine glucuronidation in the human fetal and adult liver
54. Morphine-6-glucuronide, a potent mu agonist
55. Opioid tolerance and responsiveness: Research findings and clinical observations
56. Effects of estradiol and testosterone on pharmacodynamics and pharmacokinetics of morphine in male rats
57. Estradiol and progesterone effects on morphine-induced antinociception in ovariectomized rats
58. cAMP accumulation in opioid-sensitive SH-SY5Y neuroblastoma cells is modified by estradiol and progesterone
59. Morphine excitation: Effects on field potential recorded in the in vitro hippocampal slices
60. Gender determinants of opioid mediation of swim analgesia in rats
61. Sex differences in the excretion of glucuronide conjugates: The role of intrarenal glucuronidation
62. Role of morphine glucuronide metabolites in morphine dependence in the rat
63. Sex differences in morphine analgesia: An experimental study in healthy volunteers
64. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment
65. Analgesic effect of morphine glucuronides
66. A preliminary study on the distribution of morphine and its glucuronides in the subcompartments of blood
67. Morphine-3-glucuronide: Evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat
68. Morphine-3-glucuronide - A potent antagonist of morphine analgesia
69. A method for frequent sampling of blood and continuous infusion of fluids in the rat without disturbing the animal
70. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine
71. Determination of morphine, M3G and M6G using ion-pair high performance liquid chromatography
72. Morphine-6-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies
73. Fast reliable assay for morphine and its metabolites using high-performance liquid chromatography and native fluorescence
74. Human brain metabolism of morphine and naloxone
75. Plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide after intravenous and oral administration to healthy volunteers: Relationship to nonanalgesic actions
76. Intrathecal high dose morphine produced hyperalgesia in the rat
77. Biochemical basis for analgesic activity of morphine-6-glucuronide-1: Penetration of morphine-6-glucuronide in the brain of rats